STAAR Surgical Co (STAA) stock

STAANasdaqOphthalmic GoodsFiscal year ends January 2

Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30

$26.78+0.09 (+0.34%)

Close on Nov 12, 2026Market cap $1.34BP/E –Yield –

STAAR Surgical EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

STAAR Surgical's EV/EBITDA was 84.2× on Nov 11, 2026, against 78.0× a year earlier. Over the last 5 years it ranged from 37.2× to 918.9×, with a median of 77.4×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	84.2×	+47.0
2025	Jan 31, 2025	37.2×	−0.2
2024	Dec 31, 2024	37.4×	−34.2
2023	Dec 29, 2023	71.6×	+29.2
2022	Dec 30, 2022	42.4×	−95.8
2021	Dec 31, 2021	138.2×	−561.4
2020	Dec 31, 2020	699.5×	+563.4
2019	Dec 31, 2019	136.2×	−178.5
2018	Dec 31, 2018	314.6×	−510.6
2014	Jan 31, 2014	825.3×	+12.0
2013	Dec 31, 2013	813.2×	+521.2
2012	Dec 31, 2012	292.1×	+39.7
2011	Dec 30, 2011	252.4×	–

Where these numbers come from

Parsed from the XBRL in STAAR Surgical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-2 reverse split on May 18, 1992
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing